Multiple Sclerosis May Stop In High-Risk Treatment
A risky therapy for multiple sclerosis (MS), which can stop the disease for as long as five years, is now being tested in patients. Doctors say that the high-risk therapy involves resetting the patient's immune system with doses of strong cancer drugs, and then restarting it with a stem cell transplant. Due to its dangerous nature, only selected patients will be qualified to try the therapy.
In fact, eight of the patients who underwent the clinical trial for the treatment died shortly afterwards. However, out of 281 people test subjects, nearly half experience significant improvement from the therapy. Published in JAMA Neurology, the clinical study is one of the largest and longest investigations of this aggressive MS treatment.
Although considered to be non-fatal, MS is incurable. The neuromuscular disease attacks the protective lining of nerves in the brain and spinal cord, creating disturbances with a person's movement, and even vision. Walking and balancing becomes a great challenge, rendering patients in wheelchairs.
The disease causes the immune system to attack the protective coating of nerves in the brain and spinal cord, which can create problems with a person's vision, walking and balance. The Multiple Sclerosis Foundation estimates that more than 400,000 people in the United States and about 2.5 million people worldwide have MS. Each week, about 200 new cases are diagnosed in the US, with.rates of patients higher in cold climate regions.
According to the Emax Health, treatments for the disease aim to slow or stop the attack. The idea is to reset the immune system to stop it from attacking the body. However, it requires toxic cancer drugs to wipe out existing cells in the patient's bone marrow, which is often hazardous.
Researchers from Imperial College London gathered data from 25 centers in 13 countries that have tested autologous haematopoietic stem cell transplantation (AHSCT). The radical therapy promises to completely relieve MS symptoms for up to five years. However, the medical trial data suggest that only patients who are younger, who do not respond to other therapy, and who have recurring MS, might benefit, the BBC reports.
Dr Paolo Muraro, lead investigator explains that the risks must be carefully weighed up against the benefits. Doctors and patients must take into account that the treatment carries a small risk of death on a disease that is not immediately life-threatening, he adds. Advanced clinical trials are already conducted to test how well AHSCT works compared to existing treatments for Multiple Sclerosis.
Bad Cholesterol: Very Low Level Puts You At Risk For Cataract
Researchers have found that a very low level of LDL, or bad cholesterol, increases the risks of cataract. Statins were also found to have no other significant adverse effects except for the visual disorder.
Heart Attack Risk Can Now Be Tested By Gut Bacteria
A new blood test effectiviely diagnoses heart attack risks by identifying the presence of a certain gut bacteria. The test determines the occurrence of heart complications within one month up to seven years.
Diabetes News: Virus Found In Feces Linked To Diabetes Type 1
The latest on diabetes news confirms that virus from feces has been definitively linked to the development of type 1 Diabetes. The study opens up the oppotunity to developm a vaccine to preven the disorder in the near future.
The Controversial ‘Liberation Therapy’: Is It Good For Multiple Sclerosis?
With the number of advancements that has been intended for Multiple Sclerosis, why is the so-called ‘Liberation Therapy’ found to ineffective? What makes the said therapy to be considered as a failure when it comes to treating the auto-immune disease? Could it mean that it’s now a hopeless case for one of the world’s most dreaded diseases? Here’s what experts have to say
Multiple Sclerosis May Now Be Predicted Through Fatigue And Leg Dysfunction, Experts Say
Considering that the emergence of Multiple Sclerosis is still being considered as mysterious, are there ways to predict if a person is at risk of developing the said auto-immune disease? What’s the truth behind claims that Fatigue and Leg Dysfunction may be used as onset identifiers of the disease? Find out what health experts have to say
Recovery From Multiple Sclerosis Found In The So-Called 'tDCs' Technology, Details Inside
What is 'tDCs'? Considering that Multiple Sclerosis has been one of the world's fast emerging diseases, can the cure be found in this new technology called 'tDCs'? How can a patient recover from the aid auto-immune disease with the help of this technology? Here's what health professionals have to say
MORE IN ITECHPOST
Invoice Templates - Finances Made Easy
Contractors offer a wide variety of services, be it consulting or remodeling. Whatever the service being offered, however, a contractor needs to be paid after the conclusion of the work. This is why contractor invoices play a crucial role, especially for independent contractors. A contractor invoice is used generally by people who work independently to request payment of the fee charged for services provided to the customer.
How Do Personal Emergency Response Systems Work?
Personal emergency response systems, known as PERS for short, are systems that help people to raise the alarm and get immediate help when a medical or personal emergency occurs. They are ideal for older people and anyone with a mobility issue or an injury or illness that can cause falls.
Eight Must-Have Tools to Keep Your Car Out of Garage
We all dread taking our car to a garage for repairs. We might just want to avoid the inconvenience of being off the road or maybe the costs associated, which can even lead to knock-on effects on things like our holiday plans.
6 Hacks for Students to Choose a Laptop While on a Budget
The modern world tries to drown us in the sea of choices. One can’t simply buy a laptop - there are hundreds of laptops around and sometimes our budget becomes the only real limitation we can rely on. But how to choose other parameters to get the best laptop possible?